EUVIMEDOpdag EUVIMED
Open access

MFN2-associated astrocyte dysfunction contributes to neuronal hyperexcitability and depressive-like behaviors

Feng-Xia Ma iD, Min Wang, Shuo-Yan Fang, Xiao-Xin Wang, Shen-Han Xu, Xin-Xin Zhao, Yu-Xiao Liu, Cong Wang, Chen Qiao iD, Qiu-Ling Wang iD, Lei Cao iD

Science Advances · 2026-10-16 · 12 (42)

DOI: 10.1126/sciadv.aed8795 ↗

At a glance

Journal article in Science Advances, published on 2026-10-16. Written by Feng-Xia Ma and 10 co-authors. Institution: Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing 211166, China. Major MEDLINE topics: Astrocytes, GTP Phosphohydrolases, Neurons, Depression. Cited 1 times so far (Crossref); 35 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China, National Natural Science Foundation of Jiangsu Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Astrocyte pathology is increasingly recognized as a key factor in the pathogenesis of major depressive disorder (MDD), where disrupted glutamate clearance and impaired neuron-glia interactions contribute to synaptic dysfunction. However, the molecular mechanisms leading to astrocyte loss remain largely undefined. Mitochondrial dysfunction is a hallmark of MDD, yet most studies have focused on neuronal mitochondria, leaving astrocytic mitochondrial dynamics insufficiently investigated. Here, we identify mitofusin-2 (MFN2)–associated astrocyte dysfunction in depression. SMART-seq profiling of hippocampal astrocytes from chronic social defeat stress (CSDS) mice revealed Mfn2 up-regulation, accompanied by excessive mitochondrial fusion, impaired mitophagy, and astrocyte loss. Elevated MFN2 expression was detected in plasma, postmortem brain tissue, and iPSC-derived astrocytes from patients with MDD. Astrocyte-specific knockdown of Mfn2 restored mitochondrial morphology and mitophagy, thereby preserving astrocyte viability and alleviating depressive-like behaviors. Using mass spectrometry–based label-free proteomics, in vivo calcium imaging, and functional assays, we demonstrated that β-arrestin2 deficiency reduced STAT1 stability, releasing its transcriptional repression on Mfn2 . Normalization of MFN2 expression through astrocytic Mfn2 knockdown or Stat1 overexpression reduced extracellular glutamate accumulation and prevented neuronal hyperexcitability in CSDS mice. Collectively, our findings define astrocytic MFN2-associated astrocyte dysfunction as a central pathological event in depressive behaviors, with the β-arrestin2–STAT1 pathway acting as an upstream regulatory mechanism. This work reveals an astrocytic pathway in depression and highlights a potential therapeutic target that directly addresses astrocyte pathology, beyond the neuron-centered focus of current antidepressant treatments.

Subjects

MeSH terms (MEDLINE)

AstrocytesGTP PhosphohydrolasesNeuronsDepressionMajor Depressive DisorderAnimalsMiceHumansMitochondriaMaleHippocampusMitophagyDisease Models, AnimalSTAT1 Transcription FactorMitochondrial DynamicsMitochondrial Proteins

Substances

GTP PhosphohydrolasesMfn2 protein, mouseSTAT1 Transcription FactorMFN2 protein, humanMitochondrial Proteins

Authors and institutions

  • Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing 211166, China.
  • Changzhou Second People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou 213000, China.
  • Department of Clinical Pharmacy, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang 212001, Jiangsu, China.
  • School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China.

ORCID profiles: Feng-Xia Ma, Chen Qiao, Qiu-Ling Wang, Lei Cao

Funding

  • National Natural Science Foundation of China
  • National Natural Science Foundation of Jiangsu Province

Cite

APA

Ma, F. X., Wang, M., Fang, S. Y., Wang, X. X., Xu, S. H., Zhao, X. X., Liu, Y. X., Wang, C., Qiao, C., Wang, Q. L., & Cao, L. (2026). MFN2-associated astrocyte dysfunction contributes to neuronal hyperexcitability and depressive-like behaviors. Science Advances, 12(42). https://doi.org/10.1126/sciadv.aed8795

Vancouver

Ma FX, Wang M, Fang SY, Wang XX, Xu SH, Zhao XX, et al. MFN2-associated astrocyte dysfunction contributes to neuronal hyperexcitability and depressive-like behaviors. Science Advances. 2026;12(42). doi:10.1126/sciadv.aed8795

BibTeX
@article{Ma2026,
  author = {Ma, Feng-Xia and Wang, Min and Fang, Shuo-Yan and Wang, Xiao-Xin and Xu, Shen-Han and Zhao, Xin-Xin and Liu, Yu-Xiao and Wang, Cong and Qiao, Chen and Wang, Qiu-Ling and Cao, Lei},
  title = {MFN2-associated astrocyte dysfunction contributes to neuronal hyperexcitability and depressive-like behaviors},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {42},
  doi = {10.1126/sciadv.aed8795}
}
Start for free →